PMC:7170415 / 76-702 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"15","span":{"begin":97,"end":104},"obj":"Species"},{"id":"16","span":{"begin":119,"end":172},"obj":"Species"},{"id":"17","span":{"begin":176,"end":186},"obj":"Species"},{"id":"18","span":{"begin":524,"end":531},"obj":"Species"},{"id":"23","span":{"begin":105,"end":113},"obj":"Disease"},{"id":"24","span":{"begin":188,"end":197},"obj":"Disease"},{"id":"25","span":{"begin":243,"end":251},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Tax:9606"},{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Tax:694009"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Tax:2697049"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Tax:9606"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"MESH:D007239"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"MESH:D007239"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"-2\nA Narrative Review\nDiagnostic Testing for SARS–CoV-2\n\nAbstract\nDiagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laborat"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":340,"end":345},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"}],"text":"-2\nA Narrative Review\nDiagnostic Testing for SARS–CoV-2\n\nAbstract\nDiagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laborat"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":45,"end":49},"obj":"Disease"},{"id":"T3","span":{"begin":119,"end":152},"obj":"Disease"},{"id":"T4","span":{"begin":176,"end":180},"obj":"Disease"},{"id":"T5","span":{"begin":188,"end":197},"obj":"Disease"},{"id":"T6","span":{"begin":243,"end":251},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"-2\nA Narrative Review\nDiagnostic Testing for SARS–CoV-2\n\nAbstract\nDiagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laborat"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":3,"end":4},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T3","span":{"begin":33,"end":40},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T4","span":{"begin":77,"end":84},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T5","span":{"begin":280,"end":281},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T6","span":{"begin":319,"end":326},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T7","span":{"begin":330,"end":331},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T8","span":{"begin":346,"end":349},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T9","span":{"begin":355,"end":356},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T10","span":{"begin":459,"end":466},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T11","span":{"begin":477,"end":480},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T12","span":{"begin":493,"end":500},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T13","span":{"begin":617,"end":618},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"-2\nA Narrative Review\nDiagnostic Testing for SARS–CoV-2\n\nAbstract\nDiagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laborat"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":551,"end":564},"obj":"http://purl.obolibrary.org/obo/GO_0003968"},{"id":"T2","span":{"begin":551,"end":564},"obj":"http://purl.obolibrary.org/obo/GO_0003899"}],"text":"-2\nA Narrative Review\nDiagnostic Testing for SARS–CoV-2\n\nAbstract\nDiagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laborat"}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":3,"end":21},"obj":"Sentence"},{"id":"T3","span":{"begin":22,"end":55},"obj":"Sentence"},{"id":"T4","span":{"begin":57,"end":65},"obj":"Sentence"},{"id":"T5","span":{"begin":66,"end":276},"obj":"Sentence"},{"id":"T6","span":{"begin":277,"end":406},"obj":"Sentence"},{"id":"T7","span":{"begin":407,"end":532},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"-2\nA Narrative Review\nDiagnostic Testing for SARS–CoV-2\n\nAbstract\nDiagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laborat"}